Effects of mixed subchronic lead acetate and cadmium chloride on bone metabolism in rats

Guiping Yuan; Hongke Lu; Zhongqiong Yin; Shujun Dai; Renyong Jia; Jiao Xu; Xu Song; Li Li
June 2014
International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 5, p1378
Academic Journal
This study aimed to determine the effects of administering a mixture of subchronic lead acetate (Pb (NO3)2) and cadmium chloride (CdCl2·2.5H2O) on the bone metabolism of rats. A control group and three experimental groups consisted of randomly selected rats. Rats in each experimental group were orally administered with a mixture of Pb (NO3)2 and CdCl2·2.5H2O with the following respective doses for 90 consecutive days: 0 mg/kg body weight b.w. (Group I, to serve as a control), 29.96 mg/kg b.w. (Group II, 29.25 + 0.71), 89.88 mg/kg b.w. (Group III, 87.74 + 2.14), and 269.65 mg/kg b.w. (Group IV, 263.23 + 6.42). Serum osteocalcin (OC) and bone-specific alkaline phosphates (BALP) were considered as bone-formation markers, whereas carboxy-terminal cross-linking telopeptides of type I collagen (CTX) in serum acted as bone resorption markers. Calcitonin (CT) and parathormone (PTH) were tested as calciotropic hormones markers. The (Ca) and phosphorus (Pi) concentrations in the serum and urine were determined. These results were indicated by a significant (P < 0.05 - P < 0.01) increase in BALP, CTX, and PTH concentrations and decrease in CT and OC concentrations. Moreover, the concentrations of Ca and Pi in the serum were decreased, whereas those in urine increased. Results indicated that the administration of Pb and Cd induced bone metabolism disorders by decreasing bone formation and increasing bone resorption to destroy the hormonal regulation of mineral metabolism as a result of Ca and Pi imbalance.


Related Articles

  • Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary - results from a nationwide clinical audit. Kiss, István; Kiss, Zoltán; Ambrus, Csaba; Szabó, András; Szegedi, János; Balla, József; Ladányi, Erzsébet; Csiky, Botond; Árkossy, Ottó; Török, Marietta; Túri, Sándor; Kulcsár, Imre // BMC Nephrology;2013, Vol. 14 Issue 1, p1 

    Background: Achieving target levels of laboratory parameters of bone and mineral metabolism in chronic kidney disease (CKD) patients is important but also difficult in those living with end-stage kidney disease. This study aimed to determine if there are age-related differences in chronic kidney...

  • Mineral and Bone Disorders in Patients on Dialysis: Physiology and Clinical Consequences. McCarley, Patricia B.; Arjomand, Mahiyar // Nephrology Nursing Journal;Jan/Feb2008, Vol. 35 Issue 1, p59 

    Chronic kidney disease-mineral and bone disorder (CKD-MBD) arises from a series of independent, yet interrelated, disturbances in bone and mineral metabolism. The consequences of failing to control CKD-MBD include increased mortality, cardiovascular and soft-tissue calcification, renal...

  • Fibroblast growth factor 23. Smith, Edward R; McMahon, Lawrence P; Holt, Stephen G // Annals of Clinical Biochemistry;Mar2014, Vol. 51 Issue 2, p203 

    There is growing interest in the role of fibroblast growth factor 23 (FGF23) in various diseases of disordered mineral metabolism. In chronic kidney disease (CKD), where biochemical evidence of mineral disturbances is especially common, FGF23 measurement has been advocated as an early and...

  • THE PREVALENCE OF BIOCHEMICAL ABNORMALITIES OF CHRONIC KIDNEY DISEASE. MINERAL AND BONE DISORDERS IN UNTREATED NON-DIALYSIS PATIENTS - A MULTICENTER STUDY. Căpușă, C.; Chirculescu, B.; Vladu, I.; Viaşu, L.; Lipan, M.; Moţa, E.; Mircescu, G. // Acta Endocrinologica (1841-0987);Jul-Sep2016, Vol. 12 Issue 3, p282 

    Background. There are scarce data about prevalence of mineral metabolism (MM) disorders in Romanian predialysis patients, so we assessed their occurrence and relationships in mild to severe chronic kidney disease (CKD). Methods. One hundred fifteen non-dialysis CKD (eGFR 31, 95% CI 29-35mL/min)...

  • A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease. Rodriguez, Mariano; Salmeron, M. Dolores; Martin-Malo, Alejandro; Barbieri, Carlo; Mari, Flavio; Molina, Rafael I.; Costa, Pedro; Aljama, Pedro // PLoS ONE;1/25/2016, Vol. 11 Issue 1, p1 

    Background: In hemodialysis patients, deviations from KDIGO recommended values of individual parameters, phosphate, calcium or parathyroid hormone (PTH), are associated with increased mortality. However, it is widely accepted that these parameters are not regulated independently of each other...

  • Acrolein depletes the neuropeptide CGRP and substance P in sensory nerves in rat respiratory tract Noel, C.; Bloom, S. R.; Edginton, J. A. G.; Polak, J. M.; Price, P. N.; Springall, D. R.; Swanston, D. W. // Environmental Health Perspectives;Apr1990, Vol. 85, p151 

    No abstract available.

  • Binding of CGRP Analogs and their Effect on Adenylate Cyclase Activity in Porcine Iris-Ciliary Body. Heino, Paivi; Oksala, Olli; Palkama, Arto; Valo, Tuula; Vihavainen, Sari; Koskinen, Ari; Uusitalo, Hannu // Journal of Ocular Pharmacology & Therapeutics;Dec98, Vol. 14 Issue 6, p543 

    Studies the structure-activity relationship of the calcitonin gene-related peptide (CGRP) in the porcine iris-ciliary body using different CGRP analogs. Information about CGRP; Details of adenylate cyclase assay; Where CGRP immunoreactive sensory nerves are found.

  • Calcintonin gene related peptide. O'Halloran, Domhnall J.; Bloom, S.R. // BMJ: British Medical Journal (International Edition);3/30/91, Vol. 302 Issue 6779, p739 

    Examines the existence of calcitonin gene related peptide in Great Britain. Isolation of peptide from human medullary carcinoma; Essence of the peptide on the neurotransmitter in the peripheral sensory nervous system; Capabilities of calcitonin gene related peptide.

  • Alopecia may involve low levels of thyroid protein. Guttman, Cheryl // Dermatology Times;Sep98, Vol. 19 Issue 9, p1 

    Focuses on low levels of calcitonin gene-related protein (CGRP) which may be the cause alopecia areata. Background of a study using radioimmunossay techniques to measure levels of peptide produce by thyroid C cells; Significance of CGRP to the human body; Implication of the finding to patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics